Startups
Edit
European Association for the Study of Diabetes
https://www.easd.org/Last activity: 26.08.2026
Probably Closed
Promoting excellence in diabetes care since 1965.
Overview
Location
Germany, North Rhine-Westphalia, Dusseldorf
Employees
11-50
Phone
+49 211 7584690
Founded date
1965
Mentions in press and media 23
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 23, 2026 | Ascletis Announces Oral Discussion of ASC36_35 FDC Preclinical Data Demonstrating Superior Weight Loss to Eloralintide/Tirzepatide Combination at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting | - Fixed-dose combination of ASC36 and ASC35 (ASC36_35 FDC) demonstrated superior weight loss compared to eloralintide in combination with tirzepatide in a diet-induced obese (DIO) animal model. HONG KONG, July 23, 2026 /PRNewswire/ -- Ascle... |
| Mar 6, 2026 | Sciwind Biosciences Announces Ecnoglutide Injection Approved by China's National Medical Products Administration (NMPA) for Chronic Weight Management | HANGZHOU, China, March 6, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind"), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic diseases, announced toda... |
| Jan 13, 2026 | diaTribe Convenes International Consensus to Guide Diabetes Technology Use During Pregnancy | Expert recommendations provide crucial guidance to leverage CGM and AID during pregnancy. SAN FRANCISCO, Jan. 13, 2026 /PRNewswire/ -- The diaTribe Foundation announces the publication of the first international consensus statement on the u... |
| Oct 15, 2025 | Sinocare Showcases Its Comprehensive Diabetes Management Solutions at EASD | VIENNA, Oct. 15, 2025 /PRNewswire/ -- The 61st Annual Meeting of the European Association for the Study of Diabetes (EASD 2025) was successfully held in Vienna, Austria. During the conference, Sinocare hosted an international industry sympo... |
| Sep 19, 2025 | Innovent Announces Mazdutide Received Approval from China's NMPA for Glycemic Control in Adults with Type 2 Diabetes | SAN FRANCISCO and SUZHOU, China, Sept. 19, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for... |
| Sep 18, 2025 | QL Biopharm reports Phase 2 results of a monthly dose study evaluating zovaglutide, a novel, extended half-life GLP-1 receptor agonist at EASD 2025 | Patients who received zovaglutide at a once-monthly dose of 160 mg experienced a 13.8% reduction in body weight at 24 weeks, highly comparable to reductions observed in patients who received 80 mg every other week (12.5%) The overall safety... |
| Sep 17, 2025 | Ascletis Presented Results from Cohorts 1 and 2 of 28-day Multiple Ascending Dose Study of Its Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting | - ASC30 once-daily oral tablet demonstrated up to 6.5% placebo-adjusted mean body weight reduction from baseline after 28-day treatment. - ASC30 tablet's higher efficacy is supported by its higher oral drug exposures. - ASC30 is safe and we... |
| Sep 15, 2025 | Sigrid Therapeutics Builds Momentum: Positive SHINE Trial, Early Real-World Evidence, and CE-Mark Submission in Progress | Sigrid Therapeutics Builds Momentum: Positive SHINE Trial, Early Real-World Evidence, and CE-Mark Submission in Progress Mon, Sep 15, 2025 08:30 CET Report this content Stockholm, Sweden – September 15, 2025 – Sigrid Therapeutics, the innov... |
| Sep 11, 2025 | New analysis to be presented at EASD supports potential of Diamyd[®] to delay the progression of Stage 3 Type 1 Diabetes | New analysis to be presented at EASD supports potential of Diamyd[®] to delay the progression of Stage 3 Type 1 Diabetes Thu, Sep 11, 2025 10:00 CET Report this content A new retrospective analysis of clinical data from 241 individuals with... |
Show more
Reviews 0
FAQ about European Association for the Study of Diabetes
When was European Association for the Study of Diabetes founded?
European Association for the Study of Diabetes was founded in 1965.
What has the press written about European Association for the Study of Diabetes?
Parsers VC has collected 23 articles mentioning European Association for the Study of Diabetes, among them “Ascletis Announces Oral Discussion of ASC36_35 FDC Preclinical Data Demonstrating Superior Weight Loss to Eloralintide/Tirzepatide Combination at the 62nd Eu...” (Jul 23, 2026) and “Sciwind Biosciences Announces Ecnoglutide Injection Approved by China's National Medical Products Administration (NMPA) for Chronic Weight Management” (Mar 6, 2026).
Is European Association for the Study of Diabetes still active?
European Association for the Study of Diabetes is probably closed: its latest activity on Parsers VC dates from Aug 26, 2026.